| Type | MGI:General | Description | 4 weeks after tamoxifen administration, mice exhibit end-stage cardiomyopathy characterized by severely decreased wall motion and increased dilatation without a change in heart rate 4 weeks after tamoxifen administration, mice show scarring of the hearts associated with accumulating collagen deposits |
